title: There is level 1 evidence for intensive glycemic control for reducing the progression of diabetic retinopathy in persons with type 2 diabetes.
authors.affiliation: Division of Epidemiology and Clinical Applications, National Eye Institute/National Institutes of Health, Building 10, CRC, Room 3-2531, 10 Center Drive, MSC-1204, Bethesda, MD, 20892-1204, USA, echew@nei.nih.gov.
authors.forename: Emily Y
authors.initials: EY
authors.lastname: Chew
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D048909:Diabetes Complications / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012164:Retinal Diseases / Q000188:drug therapy*
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents